These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20810657)

  • 1. A key role for the phosphorylation of Ser440 by the cyclic AMP-dependent protein kinase in regulating the activity of the Src homology 2 domain-containing Inositol 5'-phosphatase (SHIP1).
    Zhang J; Ravichandran KS; Garrison JC
    J Biol Chem; 2010 Nov; 285(45):34839-49. PubMed ID: 20810657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.
    Zhang J; Walk SF; Ravichandran KS; Garrison JC
    J Biol Chem; 2009 Jul; 284(30):20070-8. PubMed ID: 19494109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.
    Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh WM; Tempst P; Clarkson B
    Blood; 1999 Apr; 93(8):2707-20. PubMed ID: 10194451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia-associated mutations in SHIP1 inhibit its enzymatic activity, interaction with the GM-CSF receptor and Grb2, and its ability to inactivate PI3K/AKT signaling.
    Brauer H; Strauss J; Wegner W; Müller-Tidow C; Horstmann M; Jücker M
    Cell Signal; 2012 Nov; 24(11):2095-101. PubMed ID: 22820502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 1. Effects on inflammatory cell activation and chemotaxis in vitro and pharmacokinetic characterization in vivo.
    Stenton GR; Mackenzie LF; Tam P; Cross JL; Harwig C; Raymond J; Toews J; Wu J; Ogden N; MacRury T; Szabo C
    Br J Pharmacol; 2013 Mar; 168(6):1506-18. PubMed ID: 23121445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SH2 inositol 5-phosphatase Ship1 is recruited in an SH2-dependent manner to the erythropoietin receptor.
    Mason JM; Beattie BK; Liu Q; Dumont DJ; Barber DL
    J Biol Chem; 2000 Feb; 275(6):4398-406. PubMed ID: 10660611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism.
    An H; Xu H; Zhang M; Zhou J; Feng T; Qian C; Qi R; Cao X
    Blood; 2005 Jun; 105(12):4685-92. PubMed ID: 15701712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src homology 2 domain-containing inositol 5-phosphatase 1 mediates cell cycle arrest by FcgammaRIIB.
    Malbec O; Schmitt C; Bruhns P; Krystal G; Fridman WH; Daëron M
    J Biol Chem; 2001 Aug; 276(32):30381-91. PubMed ID: 11359765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms controlling membrane recruitment and activation of the autoinhibited SHIP1 inositol 5-phosphatase.
    Waddell GL; Drew EE; Rupp HP; Hansen SD
    J Biol Chem; 2023 Aug; 299(8):105022. PubMed ID: 37423304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible Ser/Thr SHIP phosphorylation: a new paradigm in phosphoinositide signalling?: Targeting of SHIP1/2 phosphatases may be controlled by phosphorylation on Ser and Thr residues.
    Edimo WE; Janssens V; Waelkens E; Erneux C
    Bioessays; 2012 Aug; 34(8):634-42. PubMed ID: 22641604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12.
    Parihar R; Trotta R; Roda JM; Ferketich AK; Tridandapani S; Caligiuri MA; Carson WE
    Cancer Res; 2005 Oct; 65(19):9099-107. PubMed ID: 16204085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SH2-domain of SHIP1 interacts with the SHIP1 C-terminus: impact on SHIP1/Ig-α interaction.
    Mukherjee O; Weingarten L; Padberg I; Pracht C; Sinha R; Hochdörfer T; Kuppig S; Backofen R; Reth M; Huber M
    Biochim Biophys Acta; 2012 Feb; 1823(2):206-14. PubMed ID: 22182704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHIP1 and Lyn Kinase Negatively Regulate Integrin alpha IIb beta 3 signaling in platelets.
    Maxwell MJ; Yuan Y; Anderson KE; Hibbs ML; Salem HH; Jackson SP
    J Biol Chem; 2004 Jul; 279(31):32196-204. PubMed ID: 15166241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth.
    Séverin S; Gratacap MP; Lenain N; Alvarez L; Hollande E; Penninger JM; Gachet C; Plantavid M; Payrastre B
    J Clin Invest; 2007 Apr; 117(4):944-52. PubMed ID: 17347685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase.
    Bago R; Malik N; Munson MJ; Prescott AR; Davies P; Sommer E; Shpiro N; Ward R; Cross D; Ganley IG; Alessi DR
    Biochem J; 2014 Nov; 463(3):413-27. PubMed ID: 25177796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Src homology 2-containing inositol 5-phosphatase 1 (SHIP1) is involved in CD32a signaling in human neutrophils.
    Vaillancourt M; Levasseur S; Tremblay ML; Marois L; Rollet-Labelle E; Naccache PH
    Cell Signal; 2006 Nov; 18(11):2022-32. PubMed ID: 16682172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells.
    Ong CJ; Ming-Lum A; Nodwell M; Ghanipour A; Yang L; Williams DE; Kim J; Demirjian L; Qasimi P; Ruschmann J; Cao LP; Ma K; Chung SW; Duronio V; Andersen RJ; Krystal G; Mui AL
    Blood; 2007 Sep; 110(6):1942-9. PubMed ID: 17502453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ENU-induced mouse mutant of SHIP1 reveals a critical role of the stem cell isoform for suppression of macrophage activation.
    Nguyen NY; Maxwell MJ; Ooms LM; Davies EM; Hilton AA; Collinge JE; Hilton DJ; Kile BT; Mitchell CA; Hibbs ML; Jane SM; Curtis DJ
    Blood; 2011 May; 117(20):5362-71. PubMed ID: 21421839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The two SH2-domain-containing inositol 5-phosphatases SHIP1 and SHIP2 are coexpressed in human T lymphocytes.
    Bruyns C; Pesesse X; Moreau C; Blero D; Erneux C
    Biol Chem; 1999; 380(7-8):969-74. PubMed ID: 10494849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inositol phosphatase SHIP1 is a primary target of miR-155.
    O'Connell RM; Chaudhuri AA; Rao DS; Baltimore D
    Proc Natl Acad Sci U S A; 2009 Apr; 106(17):7113-8. PubMed ID: 19359473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.